MSB 2.51% 97.0¢ mesoblast limited

Ann: Mesoblast Update on COVID-19 ARDS Trial, page-309

  1. 571 Posts.
    lightbulb Created with Sketch. 160
    Ah yes the old blame the FDA game. Apparently some new leadership in the FDA will increase the efficacy of the cells...
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.